Filtz Annalisa, Lorenzatti Daniel, Scotti Andrea, Piña Pamela, Fernandez-Hazim Carol, Huang Dou, Ippolito Paul, Skendelas John P, Kuno Toshiki, Rodriguez Carlos J, Schenone Aldo L, Latib Azeem, Lavie Carl J, Shaw Leslee J, Blankstein Ron, Shapiro Michael D, Garcia Mario J, Berman Daniel S, Dey Damini, Virani Salim S, Slipczuk Leandro
Cardiology Division, Montefiore Medical Center/Albert Einstein College of Medicine. Bronx, NY, USA.
IRCCS Ospedale Ca' Granda Maggiore Policlinico, Università degli Studi di Milano. Milan, Italy.
Am J Prev Cardiol. 2024 Jul 20;19:100711. doi: 10.1016/j.ajpc.2024.100711. eCollection 2024 Sep.
OBJECTIVE: Epicardial adipose tissue (EAT) is implicated in the pathogenesis and progression of coronary artery disease (CAD). Limited data exists on the interplay between EAT and atherosclerosis in young individuals. Our study aims to explore the relationship between EAT and CAD in a young cohort. METHODS: All young (18-45 years) patients without prior CAD, referred for coronary computed tomography angiography (CCTA) from 2016 to 2022 were included. EAT volume and coronary artery calcium (CAC) were calculated from dedicated non-contrast scans. Coronary plaque presence, extent, and volume were quantified from CCTA. Multivariable logistic regression models for the presence of CAD, defined as any coronary atherosclerosis, were performed. RESULTS: Overall, 712 patients (39±4.8 years, 54 % female) with 45 % Hispanic, and 21 % non-Hispanic Black were included. Patients with CAD had higher EAT volume than those without (80.80 mL ± 36.00 vs 55.16 mL ± 27.92; < 0.001). In those with CAC=0, higher EAT was associated with the presence of CAD compared to lower EAT volume ( < 0.001). An EAT volume >76 mL was associated with higher CAC ( < 0.001), segment involvement score ( < 0.001), and quantitative total, non-calcified, and low-attenuation plaque volumes ( < 0.002). At multivariable analysis, EAT volume (per 10 mL, OR: 1.21; 95 %CI: 1.12-1.30; < 0.0001) was independently associated with the presence of CAD. CONCLUSION: In a diverse cohort of young adults without history of CAD and undergoing a clinically indicated CCTA, EAT volume was independently associated with the presence of CAD. Our findings highlight EAT potential as a novel marker for CAD risk-assessment and a potential therapeutic target in young patients.
目的:心外膜脂肪组织(EAT)与冠状动脉疾病(CAD)的发病机制及进展有关。关于年轻人中EAT与动脉粥样硬化之间相互作用的数据有限。我们的研究旨在探讨年轻队列中EAT与CAD之间的关系。 方法:纳入2016年至2022年期间因冠状动脉计算机断层扫描血管造影(CCTA)而就诊的所有无CAD病史的年轻(18 - 45岁)患者。通过专门的非增强扫描计算EAT体积和冠状动脉钙化(CAC)。从CCTA中量化冠状动脉斑块的存在、范围和体积。对定义为任何冠状动脉粥样硬化的CAD存在情况进行多变量逻辑回归模型分析。 结果:总共纳入了712名患者(39±4.8岁,54%为女性),其中45%为西班牙裔,21%为非西班牙裔黑人。CAD患者的EAT体积高于无CAD患者(80.80 mL±36.00 vs 55.16 mL±27.92;<0.001)。在CAC = 0的患者中,与较低EAT体积相比,较高EAT与CAD的存在相关(<0.001)。EAT体积>76 mL与较高的CAC(<0.001)、节段累及评分(<0.001)以及定量的总斑块、非钙化斑块和低衰减斑块体积(<0.002)相关。在多变量分析中,EAT体积(每10 mL,比值比:1.21;95%置信区间:1.12 - 1.30;<0.0001)与CAD的存在独立相关。 结论:在一个无CAD病史且接受临床指征CCTA的不同年轻成年人队列中,EAT体积与CAD的存在独立相关。我们的研究结果突出了EAT作为CAD风险评估新标志物以及年轻患者潜在治疗靶点的潜力。
Am J Prev Cardiol. 2024-7-20
J Cardiovasc Med (Hagerstown). 2023-4-1
Oxid Med Cell Longev. 2021
Int J Cardiol Heart Vasc. 2023-7-13
Atherosclerosis. 2009-11-20
Cardiovasc Interv Ther. 2025-4-5
Int J Cardiovasc Imaging. 2024-10
Eur Heart J Cardiovasc Imaging. 2024-7-31
J Am Coll Cardiol. 2023-11-28
N Engl J Med. 2023-12-14
Eur J Heart Fail. 2023-11
J Cardiovasc Comput Tomogr. 2024
Am J Prev Cardiol. 2023-8-22
J Cardiovasc Comput Tomogr. 2023
Cardiovasc Diabetol. 2023-1-31